戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  modify authentic platelets in a nonclinical crystalloid solution.
2  were adequately cleared (removal > 5 mL) of crystalloid solutions.
3                The CNTL involved intravenous crystalloid solutions.
4 e administration of only a minimal volume of crystalloid solution (2.8 mL/kg) and the absence of bloo
5  0.9% saline (30,994 patients) or a balanced crystalloid solution (926 patients) on the day of surger
6                   In addition, the volume of crystalloid solution administered during the first 24 hr
7 o determine whether the volumes of blood and crystalloid solutions administered in the early posttrau
8 albumin, starches, 0.9% saline, and balanced crystalloid solutions) administered and the different mo
9 ther 20% albumin and crystalloid solution or crystalloid solution alone.
10 tion to albumin and crystalloid solutions or crystalloid solutions alone.
11 d debate continues about the role of various crystalloid solutions and albumin.
12                    Pharmacologic modulation, crystalloid solution at 4 degrees C, and induction of he
13 ed method for infusion of O2, dissolved in a crystalloid solution at extremely high concentrations, i
14 0.01, 0.05, 0.10, 0.50, or 1.0 mL of various crystalloid solutions, containing or not containing RL,
15 ume-dependent and linear fashion, the non-RL crystalloid solutions decreased the lactate concentratio
16                                     Balanced crystalloid solutions (e.g., lactated Ringer's, Plasma-L
17 reserved by perfusion with a cold oxygenated crystalloid solution for 4 h, transferred to a blood per
18 porting the choice of intravenous colloid vs crystalloid solutions for management of hypovolemic shoc
19 ersus Plasma-Lyte A, a calcium-free balanced crystalloid solution, hypothesizing that Plasma-Lyte A w
20 depend on its environment and (2) ONOO(-) in crystalloid solution impairs postcardioplegia systolic a
21              c) Even small amounts of non-RL crystalloid solutions in catheters used for blood sampli
22 on of therapeutic components, beginning with crystalloid solutions infused to replace lost intravascu
23     Rationale: Administration of intravenous crystalloid solutions is a fundamental therapy for sepsi
24 on, fluid resuscitation was initiated with a crystalloid solution (Lactated Ringers).
25 ens are drawn from indwelling catheters, all crystalloid solutions must be cleared from the line.
26 ts (ICUs), to receive either 20% albumin and crystalloid solution or crystalloid solution alone.
27  either an intravenous infusion of 500 mL of crystalloid solution or no fluid bolus.
28                 Randomization to albumin and crystalloid solutions or crystalloid solutions alone.
29  deleterious effects of nitric oxide (NO) in crystalloid solutions, possibly due to a lack of detoxif
30 LP induced septic rats, whereas the balanced crystalloid solution showed stabilization of macro- and
31                                     Balanced crystalloid solutions such as Lactated Ringer are associ
32  is a physiologic, balanced multielectrolyte crystalloid solution that approximates the electrolyte c
33 st the hypothesis that even small amounts of crystalloid solutions, which are inadequately "cleared"